GRAPPA 2013 annual meeting, rheumatology updates: Psoriatic arthritis (PsA) biomarker project, arthritis mutilans, PsA-peripheral spondyloarthritis epidemiology project

8Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.

Abstract

At the 2013 annual meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), several key GRAPPA projects on musculoskeletal aspects of psoriatic disease were reviewed. In this article, lead investigators summarize the progress made in a multicenter study, the PsA BioDam (Psoriatic Arthritis Biomarkers for Joint Damage), to identify soluble biomarkers for joint damage, as well as developing classification criteria for arthritis mutilans. Also reviewed are concepts and rationale behind a proposal to study classification criteria for peripheral spondyloarthritis, including PsA, reactive arthritis, inflammatory bowel disease-associated arthritis, and undifferentiated arthritis. The Journal of Rheumatology Copyright © 2014. All rights reserved.

Cite

CITATION STYLE

APA

FitzGerald, O., Mease, P. J., Helliwell, P. S., & Chandran, V. (2014). GRAPPA 2013 annual meeting, rheumatology updates: Psoriatic arthritis (PsA) biomarker project, arthritis mutilans, PsA-peripheral spondyloarthritis epidemiology project. In Journal of Rheumatology (Vol. 41, pp. 1244–1248). Journal of Rheumatology. https://doi.org/10.3899/jrheum.140181

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free